-
1.Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same 审中-公开
标题翻译: 乙酰水杨酸的新型多晶型及其制备与使用方法公开(公告)号:US20100331285A1
公开(公告)日:2010-12-30
申请号:US12861203
申请日:2010-08-23
IPC分类号: A61K31/616 , C07C69/157 , A61P29/00 , A61P9/10 , A61P19/02
CPC分类号: C07C67/52 , C07C69/157
摘要: A polymorph of aspirin is provided by the present invention. Methods of making and using the same are also provided.
摘要翻译: 本发明提供了阿司匹林的多晶型物。 还提供了制备和使用它们的方法。
-
2.Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same 审中-公开
标题翻译: 乙酰水杨酸的新型多晶型及其制备与使用方法公开(公告)号:US20080319068A1
公开(公告)日:2008-12-25
申请号:US11909902
申请日:2006-04-25
IPC分类号: A61K31/216 , C07C69/66 , A61P25/04
CPC分类号: C07C67/52 , C07C69/157
摘要: A polymer of aspirin is provided by the present invention. Methods of making and using the same are also provided.
摘要翻译: 阿司匹林的聚合物由本发明提供。 还提供了制备和使用它们的方法。
-
3.AMORPHOUS MIRABEGRON AND PROCESSES FOR CRYSTAL FORMS OF MIRABEGRON 有权
标题翻译: MIRABEGRON的晶体形态的非晶形微米和方法公开(公告)号:US20140206729A1
公开(公告)日:2014-07-24
申请号:US14117569
申请日:2012-05-17
申请人: Vishweshwar Peddy , Rajesham Boge
发明人: Vishweshwar Peddy , Rajesham Boge
IPC分类号: A61K31/426
CPC分类号: A61K31/426 , C07D277/40
摘要: Aspects of the present invention relate to amorphous form of mirabegron, amorphous solid dispersion of mirabegron, process for its preparation, processes for preparation of a form crystal and β form crystal of mirabegron and pharmaceutical composition thereof.
摘要翻译: 本发明的方面涉及mirabegron的无定形形式,mirabegron的无定形固体分散体,其制备方法,形式晶体的制备方法和&bgr; 形成mirabegron的晶体及其药物组合物。
-
4.Amorphous mirabegron and processes for crystal forms of mirabegron 有权
标题翻译: 无定形mirabegron和晶体形式的mirabegron的过程公开(公告)号:US09283210B2
公开(公告)日:2016-03-15
申请号:US14117569
申请日:2012-05-17
申请人: Vishweshwar Peddy , Rajesham Boge
发明人: Vishweshwar Peddy , Rajesham Boge
IPC分类号: C07D277/40 , A61K31/426
CPC分类号: A61K31/426 , C07D277/40
摘要: Aspects of the present invention relate to amorphous form of mirabegron, amorphous solid dispersion of mirabegron, process for its preparation, processes for preparation of a form crystal and β form crystal of mirabegron and pharmaceutical composition thereof.
摘要翻译: 本发明的方面涉及mirabegron的无定形形式,mirabegron的无定形固体分散体,其制备方法,形式晶体的制备方法和&bgr; 形成mirabegron的晶体及其药物组合物。
-
-
-